Jump to content

User:XyZAn/sandbox/TakedaShire

From Wikipedia, the free encyclopedia

Acquisition history

[edit]

The following is an illustration of the company's major mergers and acquisitions and historical predecessors (this is not a comprehensive list):

Takeda Pharmaceutical Company

Takeda Pharmaceuticals
(Est 1781)

Syrrx
(Acq 2005)

Millennium Pharmaceuticals
(Acq 2008)

COR Therapeutics
(Acq 2002)

Cambridge Discovery Chemistry
(Acq 2000)

Leukosite
(Acq 1999)

Nycomed 
(Acq 2011)

Altana Pharma
(Pharmaceuticals div, Acq 2007)

Bradley Pharmaceuticals
(Acq 2007)

URL Pharma
(Acq 2012)

Multilaba
(Acq 2012)

Cerevance
(Neuroscience div, Spun off 2016)

TiGenix
(Acq 2018)

Shire Plc (Acq 2018)

Baxalta
(Acq 2016)

Dyax
(Acq 2015)

Foresight Biotherapeutics
(Acq 2015)

Meritage Pharma
(Acq 2015)

NPS Pharmaceuticals
(Acq 2015)

Lumena
(Acq 2014)

Fibrotech
(Acq 2014)

ViroPharma
(Acq 2013)

Lev Pharmaceuticals
(Acq 2008)

SARcode Bioscience Inc
(Acq 2013)

Premacure AB
(Acq 2013)

Lotus Tissue Repair, Inc
(Acq 2013)

FerroKin BioSciences
(Acq 2012)

Advanced BioHealing
(Acq 2011)

Movetis
(Acq 2012)

Jerini
(Acq 2008)

New River Pharmaceuticals Inc
(Acq 2007)

Transkaryotic Therapeutics
(Acq 2005)

Biochem Canada
(Acq 2001)

Richwood Pharmaceutical Company
(Acq 1997)

Pharmavene
(Acq 1997)